What is it about?
This is a comprehensive review of published information about the safety of intravenous administration of the natural amino acid i.v. levodopa (L-DOPA). Fun fact: the first administration of levodopa for Parkinson disease was intravenous, not oral.
Featured Image
Read the Original
This page is a summary of: The Human Experience with Intravenous Levodopa, Frontiers in Pharmacology, January 2016, Frontiers,
DOI: 10.3389/fphar.2015.00307.
You can read the full text:
Resources
Contributors
The following have contributed to this page
